More Big Fakers
They're going to great lengths to impersonate popular sweeties, up to and including AI-quality fake brand name packaging.
Select Page
by C. Scott McMillin | Sep 5, 2024 | Addictive Substances | 0 |
They're going to great lengths to impersonate popular sweeties, up to and including AI-quality fake brand name packaging.
by C. Scott McMillin | Jun 10, 2024 | Addictive Substances | 0 |
by C. Scott McMillin | May 6, 2024 | Addictive Substances | 0 |
by C. Scott McMillin | Apr 15, 2024 | Addictive Substances | 0 |
by C. Scott McMillin | Apr 11, 2024 | In the News | 0 |
by C. Scott McMillin | Apr 8, 2024 | In the News | 0 |
by C. Scott McMillin | Dec 4, 2023 | Addictive Substances | 0 |
Articles such as this remind me of the early days of tobacco marketing, when cigarettes were promoted as good for your health.
Read Moreby C. Scott McMillin | Oct 26, 2023 | In the News | 0 |
But, his lawyer reminds us, we shouldn’t forget that his client is ‘only’ 25 years old. Not only that, the client reportedly has assured his attorney that “…I promise you, I’m not a bad person.”
Read Moreby C. Scott McMillin | Oct 2, 2023 | Public Policy | 0 |
That was why cannabis companies set up shop in rural areas that, on the surface at least, seemed far too small to support them. They figured they wouldn’t have to.
Read Moreby C. Scott McMillin | Sep 28, 2023 | In the News | 0 |
The DEA has committed to a public information campaign around the theme of “one pill can kill”. Although that’s technically true, I don’t know how much impact it will have on the target audience.
Read Moreby C. Scott McMillin | Sep 14, 2023 | Addictive Substances | 0 |
All that free positive publicity has surely been a great help to the emerging psychedelic industry and the elements in the financial community who are rushing to exploit it.
Read Moreby C. Scott McMillin | Sep 7, 2023 | In the News | 0 |
…some patients feel ‘gypped’ if they don’t leave the office with a prescription. And respond with a bad review on the patient satisfaction survey.
Read Moreby C. Scott McMillin | Aug 31, 2023 | Addictive Substances | 0 |
As many as fifty of these NPS designer drugs have been found to date. That sounds like a lot until we realize the potential for hundreds more to appear in future.
Read Moreby C. Scott McMillin | Sep 15, 2022 | In the News | 0 |
A DC lobbyist…filed a suit claiming that John Boehner and an associated law firm had stolen his idea, and the plans for implementing it, without giving him credit (or paying him)
Read Moreby C. Scott McMillin | Sep 5, 2022 | In the News | 0 |
One thing that emerged is that Walgreen’s own pharmacists had made repeated attempts to convince corporate leadership to establish a central database of suspicious purchases, and the customers who made them.
Read Moreby C. Scott McMillin | Aug 29, 2022 | Addictive Substances, Public Policy | 0 |
More impressive results have come from simply increasing taxes on alcoholic beverages. States that have done so have been rewarded, mostly through reductions in the consequences of excessive drinking.
Read Moreby C. Scott McMillin | Jul 25, 2022 | Thinking About Addiction | 0 |
whatever McKinsey was charging for its services, their clients couldn’t have done what they did without McKinsey’s help. Sure, that led to a drug epidemic such as America has never seen, costing some half a million lives to date.
Read Moreby C. Scott McMillin | Jul 21, 2022 | In the News | 0 |
…there were some real doozies, scripts written for amounts way beyond any conceivable patient need.
Read More